Immune-Onc Therapeutics
Palo Alto
About Immune-Onc Therapeutics
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $140.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2023)
- Website: immune-onc.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/immune-onc-therapeutics-18964 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.